Cargando…
Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter]
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517420/ https://www.ncbi.nlm.nih.gov/pubmed/34675485 http://dx.doi.org/10.2147/DDDT.S341223 |
_version_ | 1784584013559627776 |
---|---|
author | Shuja, Syed Hasan Eqbal, Farea Rehman, Hafsa |
author_facet | Shuja, Syed Hasan Eqbal, Farea Rehman, Hafsa |
author_sort | Shuja, Syed Hasan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8517420 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-85174202021-10-20 Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] Shuja, Syed Hasan Eqbal, Farea Rehman, Hafsa Drug Des Devel Ther Letter Dove 2021-10-08 /pmc/articles/PMC8517420/ /pubmed/34675485 http://dx.doi.org/10.2147/DDDT.S341223 Text en © 2021 Shuja et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Letter Shuja, Syed Hasan Eqbal, Farea Rehman, Hafsa Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title | Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title_full | Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title_fullStr | Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title_full_unstemmed | Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title_short | Saroglitazar – A Potential Therapeutic Option in Treating NASH? [Letter] |
title_sort | saroglitazar – a potential therapeutic option in treating nash? [letter] |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517420/ https://www.ncbi.nlm.nih.gov/pubmed/34675485 http://dx.doi.org/10.2147/DDDT.S341223 |
work_keys_str_mv | AT shujasyedhasan saroglitazarapotentialtherapeuticoptionintreatingnashletter AT eqbalfarea saroglitazarapotentialtherapeuticoptionintreatingnashletter AT rehmanhafsa saroglitazarapotentialtherapeuticoptionintreatingnashletter |